<DOC>
	<DOCNO>NCT02275845</DOCNO>
	<brief_summary>Metformin v Control prevent gestational diabetes mellitus ( GDM ) woman high risk GDM , open label randomize control trial ' The Medico-GDM trial</brief_summary>
	<brief_title>Medico-GDM Trial - Metformine Prevent Gestational Diabetes Mellitus</brief_title>
	<detailed_description>Rationale : GDM frequent pregnancy complication1 associate complication mother child.2 At present , drug choice treatment GDM Insulin.3 In last year several study document use oral blood glucose lower medication GDM . Metformin accept alternative insulin , comparable glycemic control neonatal outcomes.4 In study woman polycystic ovarian syndrome ( PCOS ) receive Metformin pregnancy , incidence GDM le compare pregnant woman PCOS without Metformin . These study however small adequate control group.5 Our aim study effect Metformin incidence GDM woman high risk GDM . Objective : primary objective compare metformin versus intervention incidence GDM woman high risk GDM . The main secondary objective pregnancy outcome Metformin , neonatal outcome neonatal complication . Study design : 2 year open label randomize control trial , compare metformin versus control group . Study population : pregnant woman high risk GDM 18 40 year old first trimester pregnancy . Intervention : first group receive Metformin twice daily 500 mg first week , twice daily 1000 mg . The second group receive intervention . All subject receive diet contains 2000 calories/day diet , adequate distribution carbohydrate day . Main study parameters/endpoints : main study parameter difference incidence GDM two group . Nature extent burden risk associate participation , benefit group relatedness : subject visit centre first time 12 14 week pregnancy , blood sample collect . Further visit centre 24 week perform oral glucose tolerance test ( OGTT ) . Women GDM history perform OGTT 16 week first time . If OGTT borderline normal , repeat every 4 week . This accord current Dutch guidelines3 , without extra discomfort study participant . The subject visit gynaecologist obstretican regular pregnancy control . Metformin officially register use pregnancy . Long term effect unborn child know . However , previous study find neonatal pregnancy relate complication .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>subject must meet following criterion : high risk ( accord ductch national criterion ) gestational diabetes age 18 40 year gestational age 8 12 week able communicate read Dutch . A potential subject meet follow criterion exclude participation study : singleton pregnancy judge ultrasonography diagnosis diabetes mellitus current pregnancy high fasting glucose first trimester ( &gt; 5.3 mmol/l ) cardiac insufficiency\ renal insufficiency ( MDRD &lt; 60 ) liver disease use medication Paracetamol vitamins incompetent woman .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>metformin</keyword>
	<keyword>prevention</keyword>
</DOC>